Cinacalcet studies in pediatric subjects with secondary hyperparathyroidism receiving dialysis

被引：0
|
作者：
Bradley A. Warady
Eric Ng
Laura Bloss
May Mo
Franz Schaefer
Justine Bacchetta
机构：
[1] Children’s Mercy Kansas City,Division of Pediatric Nephrology
[2] Amgen Inc.,undefined
[3] Heidelberg University Hospital,undefined
[4] Department of Pediatric Nephrology,undefined
[5] Rheumatology and Dermatology,undefined
[6] Femme Mère Enfant Hospital,undefined
来源：
Pediatric Nephrology | 2020年 / 35卷
关键词：
Cinacalcet; CKD-MBD; Dialysis; Pediatric; sHPT;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1679 / 1697
页数：18
相关论文
共 50 条
  • [21] The efficacy of cinacalcet combined with conventional therapy on bone and mineral metabolism in dialysis patients with secondary hyperparathyroidism: a meta-analysis
    Li, Dan
    Shao, Leping
    Zhou, Haiyan
    Jiang, Wei
    Zhang, Wei
    Xu, Yan
    ENDOCRINE, 2013, 43 (01) : 68 - 77
  • [22] Efficacy of cinacalcet with low-dose vitamin D in incident haemodialysis subjects with secondary hyperparathyroidism
    Urena-Torres, Pablo
    Bridges, Ian
    Christiano, Cynthia
    Cournoyer, Serge H.
    Cooper, Kerry
    Farouk, Mourad
    Kopyt, Nelson P.
    Rodriguez, Mariano
    Zehnder, Daniel
    Covic, Adrian
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2013, 28 (05) : 1241 - 1254
  • [23] Effects of cinacalcet on bone mineral density and bone markers in hemodialysis patients with secondary hyperparathyroidism
    Tsuruta, Yuki
    Okano, Kazuhiro
    Kikuchi, Kan
    Tsuruta, Yukio
    Akiba, Takashi
    Nitta, Kosaku
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2013, 17 (01) : 120 - 126
  • [24] Cinacalcet treatment for secondary hyperparathyroidism in dialysis patients in real-world clinical practice - The ECHO observational study: French experience
    Urena, P.
    Fouque, D.
    Brunet, P.
    Touam, M.
    Reglier, J-C.
    NEPHROLOGIE & THERAPEUTIQUE, 2012, 8 (07): : 527 - 533
  • [25] Bone histomorphometry before and after long-term treatment with cinacalcet in dialysis patients with secondary hyperparathyroidism
    Behets, Geert J.
    Spasovski, Goce
    Sterling, Lulu R.
    Goodman, William G.
    Spiegel, David M.
    De Broe, Marc E.
    D'Haese, Patrick C.
    KIDNEY INTERNATIONAL, 2015, 87 (04) : 846 - 856
  • [26] Role of Cinacalcet in Treating Cardiac Dysfunction Secondary to Hyperparathyroidism: A Case Series
    Ohri, Alpana
    Goyal, Samridhi
    Udani, Amish
    Gupta, Madhukar
    INDIAN JOURNAL OF NEPHROLOGY, 2022, 32 (02) : 172 - 174
  • [27] Cinacalcet is effective in relapses of secondary hyperparathyroidism after parathyroidectomy
    Lomonte, Carlo
    Antonelli, Maurizio
    Losurdo, Nicola
    Marchio, Giovanni
    Giammaria, Bernardo
    Basile, Carlo
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2007, 22 (07) : 2056 - 2062
  • [28] Cinacalcet effects on the perioperative course of patients with secondary hyperparathyroidism
    Denis Wirowski
    Peter E. Goretzki
    Katharina Schwarz
    Bernhard J. Lammers
    Langenbeck's Archives of Surgery, 2013, 398 : 131 - 138
  • [29] Cinacalcet in hyperparathyroidism management after pediatric renal transplantation
    Niel, Olivier
    Maisin, Anne
    Macher, Marie-Alice
    Peuchmaur, Michel
    Deschenes, Georges
    CEN CASE REPORTS, 2016, 5 (02): : 141 - 143
  • [30] Pharmacogenetic analysis of cinacalcet response in secondary hyperparathyroidism patients
    Jeong, Sohyun
    Kim, In-Wha
    Oh, Kook-Hwan
    Han, Nayoung
    Joo, Kwon Wook
    Kim, Hyo Jin
    Oh, Jung Mi
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2016, 10 : 2211 - 2224
12345